Literature DB >> 6707030

The Indiana conservative (surface-replacement) hip arthroplasty.

W N Capello, G W Misamore, T M Trancik.   

Abstract

We reviewed the clinical results of the Indiana conservative hip arthroplasty in 116 hips with a two to seven-year follow-up. There were seventeen failures (14.6 per cent). The rate of non-traumatic loosening was 10 per cent and the failure rate for patients with inflammatory arthritis was 33 per cent. No infections, dislocations, subluxations, pulmonary emboli, or deaths were associated with the procedure. For forty-two hips with a successful result and a minimum follow-up of three years, the radiographs were analyzed. Factors that were found to have a high correlation with success of the arthroplasty were preservation of the acetabular subchondral bone, complete coverage of the acetabular component, and selection of the appropriate sizes of femoral and acetabular components. Radiolucency was not found to be a reliable diagnostic sign of, or prelude to, symptomatic loosening of the prosthetic implant.

Entities:  

Mesh:

Year:  1984        PMID: 6707030

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  4 in total

1.  Hip implant evaluation in an arthritic animal model.

Authors:  T W Phillips; K R Gurr; D R Rao
Journal:  Arch Orthop Trauma Surg       Date:  1990       Impact factor: 3.067

2.  Hip resurfacing arthroplasty: risk factors for failure over 25 years.

Authors:  Eric J Yue; Miguel E Cabanela; Gavan P Duffy; Michael G Heckman; Mary I O'Connor
Journal:  Clin Orthop Relat Res       Date:  2008-09-24       Impact factor: 4.176

Review 3.  Current trends in the management of congenital dislocation of the hip.

Authors:  G D MacEwen; G S Bassett
Journal:  Int Orthop       Date:  1984       Impact factor: 3.075

4.  Serum and urine metal levels in patients with metal-on-metal surface arthroplasty.

Authors:  Anastasia K Skipor; Patricia A Campbell; Leslie M Patterson; Harlan C Anstutz; Thomas P Schmalzried; Joshua J Jacobs
Journal:  J Mater Sci Mater Med       Date:  2002-12       Impact factor: 3.896

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.